|Articles|March 1, 2012
- Applied Clinical Trials-03-01-2012
- Volume 21
- Issue 3
Applied Clinical Trials Digital Edition - March 2012
INFORMATION TECHNOLOGY : Revolution in Randomization Clinical Database: Proper Coding and Design Also in this issue : PDUFA Renewal, EFGCP Meeting on Informed Consent, Drug Development Cycle Time, Choosing an eClinical Solution
Advertisement
Articles in this issue
over 14 years ago
Re-Imagining CTMSover 14 years ago
PDUFA Renewal Seeks Development Incentivesover 14 years ago
Biosimilar Guidances Issuedover 14 years ago
Increased eCRF Reuse Not Impacting Cycle Times?over 14 years ago
Site-Driven Metricsover 14 years ago
Rethinking the Adage Time is Moneyover 14 years ago
How Much Information for Informed Consent?over 14 years ago
New Patient Group Targets DIA EuroMeetingover 14 years ago
Subjects Share the Same ConcernsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5